AEON Biopharma
AEON
AEON
19 hedge funds and large institutions have $56.8M invested in AEON Biopharma in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.13% more ownership
Funds ownership: 0.19% → 0.32% (+0.13%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
19
Holding in Top 10
1
Calls
$576K
Puts
–
Top Buyers
| 1 | +$21.6M | |
| 2 | +$96.8K | |
| 3 | +$90K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$56.2K |
| 5 |
JP Morgan Chase
New York
|
+$38.6K |
Top Sellers
| 1 | -$3.4M | |
| 2 | -$59.4K | |
| 3 | -$34.1K | |
| 4 |
Goldman Sachs
New York
|
-$32.1K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.01K |